ArticleCancer medicine2025
The Prognosis of Urothelial Carcinoma Between Kidney Transplantation Recipients and Normal Patients: A Propensity Score-Matched Study.
Article in Cancer medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
objectiveTo evaluate the difference in the characteristics and prognosis between kidney transplantation (KT) recipients and normal patients with urothelial carcinoma.
methodWe retrospectively reviewed the characteristics of the kidney-transplanted patients and the general patients who were diagnosed with urothelial carcinoma between 2013 and 2021. The non-kidney transplantation (NKT) group is matched with the KT group through propensity score matching (PSM) to adjust for confounders. We evaluated the prognosis including overall survival (OS), relapse-free survival (RFS), and progression-free survival (PFS). We compared the difference in the prognosis between the two groups using Kaplan-Meier analysis and the log-rank test.
resultThe characteristics of 344 NKT patients and 42 KT recipients with urothelial carcinoma were included in this research. The percentage of females was significantly higher in the KT group than in the NKT group (p < 0.001). Tumors mostly occurred in the upper tract in the KT group and in the bladder cancer (BC) in the NKT group. After propensity score matching (PSM), overall survival (OS) was significantly longer in the KT group with upper tract urothelial carcinoma (UTUC) than in the NKT group (p = 0.001), whereas recurrence-free survival and progression-free survival (PFS) were significantly lower in the KT group with UTUC+BC than in the NKT group (p = 0.028, 0.044).
conclusionPatients with tumors that occur in both the bladder and upper urinary tract have a worse prognosis. Kidney transplantation recipients with only bladder or upper urinary tract UC have a prognosis that is no worse or even better than that of NKT patients.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.